Carregant...

Combined Targeting of mTOR and AKT is an Effective Strategy for Basal-like Breast Cancer in Patient-derived Xenograft Models

Basal-like breast cancer is an aggressive disease, for which targeted therapies are lacking. Recent studies demonstrated that basal-like breast cancer is frequently associated with an increased activity of the phosphatidylinositol 3-kinase (PI3K) pathway, which is critical for cell growth, survival...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Xu, Siguang, Li, Shunqiang, Guo, Zhanfang, Luo, Jingqin, Ellis, Matthew J., Ma, Cynthia X.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3742690/
https://ncbi.nlm.nih.gov/pubmed/23689832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-13-0159
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!